Delivery Order SPE2DX22D0030-SPE2D826F0CS4
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $16,601.98 to AmerisourceBergen Drug Corp on December 15, 2025, with a completion date of December 16, 2025. This firm fixed-price delivery order, issued under a competitive procurement with no set-aside designation, represents a child contract action supporting the federal government's pharmaceutical and medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,024.80 to AmerisourceBergen Drug Corp on November 4, 2025, with an ultimate completion date of November 5, 2025. This is a firm fixed-price, non-set-aside contract awarded through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and supplies a comprehensive...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $14,257.39 to AmerisourceBergen Drug Corp on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price, non-set-aside contract represents a child order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The delivery order is being performed at the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,783.04 to AmerisourceBergen Drug Corp on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price, non-competitive delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $13,407.26 to AmerisourceBergen Drug Corp on December 3, 2025, with an ultimate completion date of December 4, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,825.12 to AmerisourceBergen Drug Corp on December 12, 2025, with completion scheduled for December 15, 2025. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $45,708.52 to AmerisourceBergen Drug Corp on December 6, 2025, with a completion date of December 8, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply delivery. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,544.40 to AmerisourceBergen Drug Corp on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger prime indefinite delivery vehicle, represents a non-competitive set-aside award for pharmaceutical and medical supply fulfillment. The vendor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,069.20 to AmerisourceBergen Drug Corp on November 15, 2025, with an ultimate completion date of November 17, 2025. This is a firm fixed-price, non-set-aside contract under which AmerisourceBergen will deliver pharmaceutical products and medical supplies to support federal medical procurement needs. The award represents a child delivery order issued under a larger contract vehicle, reflecting...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $69,936.15 to AmerisourceBergen Drug Corp on December 15, 2025, with ultimate completion by December 16, 2025. This firm fixed-price, non-set-aside contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The delivery order will be performed at AmerisourceBergen's...
- SPE2DX22D0030Indefinite Delivery Contract
- SPE2DX22D0030-SPE2D826F0CS4Delivery Order
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,117.55 to AmerisourceBergen Drug Corp on December 15, 2025, with an ultimate completion date of December 16, 2025. This is a firm fixed price delivery order issued under a larger contract vehicle and represents a non-competitive award to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, supplying a comprehensive range of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, and medical devices to support military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply pharmaceutical products and medical commodities globally to support military healthcare programs. The company's federal contracting history demonstrates consistent competitive awards through open competition, positioning it as a key supplier within the DLA's pharmaceutical and medical supply procurement portfolio, which supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/14/25 |